Gabrielsen Discusses New State and Federal Efforts to Curb Prescription Opioid Abuse
February 8, 2018
Bloomberg BNA Health Law Resource Center
Associate Lindsey Gabrielsen is quoted in a Bloomberg BNA Health Law Resource Center article, “Doctors Feel the Pinch of Anti-Opioid Efforts,” about doctors’ efforts to comply with new state and federal limits on prescribing opioids.
Gabrielsen said the new limits can trip up physicians who don’t keep careful track of their prescribing history. “These government initiatives use data mining and data sharing to identify and target those physicians who prescribe more opioids than their peers, making them potential targets for government investigation,” she said.
She said doctors can take a number of practical steps to manage their opioid prescription risks, including taking the time to understand their state’s opioid prescribing laws. Focusing on documentation compliance is critical, she added. “If the government issues an investigatory subpoena for records, prescribers must be able to produce complete patient records containing notes with patient history, examination, and prescription information,” she said.
Gabrielsen said the new limits can trip up physicians who don’t keep careful track of their prescribing history. “These government initiatives use data mining and data sharing to identify and target those physicians who prescribe more opioids than their peers, making them potential targets for government investigation,” she said.
She said doctors can take a number of practical steps to manage their opioid prescription risks, including taking the time to understand their state’s opioid prescribing laws. Focusing on documentation compliance is critical, she added. “If the government issues an investigatory subpoena for records, prescribers must be able to produce complete patient records containing notes with patient history, examination, and prescription information,” she said.
Related News
July 11, 2025
In the News
Foley Attorneys Assess Critical IP Considerations for Emerging Medical Device Companies
Foley & Lardner LLP attorneys Shabbi Khan, Nate Beaver, Austin Kim, and Jeff Simon authored the Med Device Online article, "Critical Considerations For IP & Patents For Emerging Medical Device Companies."
July 11, 2025
In the News
David Morris Featured for Arrival to Foley's Salt Lake City Office
Foley & Lardner LLP partner David Morris is highlighted across legal press for his recent arrival to the firm.
July 10, 2025
In the News
Ann Marie Uetz Comments on Automotive Supply Chain Approach to Evolving Tariff Environment
Foley & Lardner LLP partner Ann Marie Uetz shared perspective from the automotive supply chain amid the evolving trade environment in the Crain's Detroit article, "Ford, Stellantis tighten terms on suppliers as tariff costs add up."